9. October 2018
credentis disclosed today that it has signed a non-exclusive distribution agreement with the Straumann Group for its non-invasive caries therapy CURODONT™ REPAIR. credentis’ unique product for Guided Enamel Regeneration will be launched as a key portfolio element for caries prevention and early caries treatment.
3. September 2018
A randomized, placebo and gold-standard controlled clinical trial (RCT), investigating the treatment of incipient buccal caries lesions with CURODONT™ REPAIR was presented at the IADR 2018 in London. In this study Prof. Krejci and his team at the University of Geneva showed that the use of CURODONT™ REPAIR is superior to that of fluoride varnish … read more
23. August 2018
Innovation is in our DNA! While credentis goes new ways to prevent and treat caries, it is strong in the development of innovative medical devices and cosmetic solutions for the professional oral care market. An additional patent for a “Method for producing a composition for treating a tooth lesion” has now been granted in the … read more